Delivery Order SPE2DR25D3009-SPE2DR26FWHD0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Atropine 8 mg/20 ml vials. This firm fixed-price delivery order, valued at $1,458.66, is scheduled for completion by October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,520.99 firm fixed price delivery order contract to supply 4,563,632,982 units of ATROPINE 8 MG/20 ML VIAL 20ML. The contract has a completion date of February 13, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a $4,324.70 delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials. This firm fixed-price contract, issued on December 10, 2025, with completion targeted for December 11, 2025, represents a child order under a larger contract vehicle. The award was made through open competition with no set-aside designation, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/mL vials with a ceiling value of $1,140.67 under a firm fixed price contract. The delivery order, issued on October 30, 2025, has an ultimate completion date of October 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was not set aside for small business or other designated categories, reflecting open competitive procurement. This delivery...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $4,324.70, is set to be completed by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,750.20 delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/ml vials, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 8 mg/20 mL vials with a ceiling value of $2,131.06. The contract is designated as firm fixed price with an ultimate completion date of December 8, 2025, and was awarded on December 5, 2025. This delivery order is unclassified as a set-aside contract and will be performed at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Atropine 1 mg/mL vials with a ceiling value of $1,014.64. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of June 30, 2025. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWHD0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp on January 6, 2026, for the supply of Atropine 8 mg/20 ml vials with a ceiling value of $2,423.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competition. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of parent company Cencora, Inc., serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's medical supply chain. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Atropine is a critical emergency medication commonly used in military and federal healthcare settings for treating nerve agent exposure and other medical emergencies, making this supply order essential to maintaining adequate inventory within the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/5/26 |